Search

Your search keyword '"Biotechnology industry -- Cases -- Intellectual property"' showing total 8 results
Start Over Descriptor "Biotechnology industry -- Cases -- Intellectual property" Publisher normans media ltd.
8 results on '"Biotechnology industry -- Cases -- Intellectual property"'

1. Court of Appeals Overturns $1.8 Billion Patent Verdict for Centocor Ortho Biotech Inc

Subjects
Johnson & Johnson -- Cases -- Intellectual property, Abbott Laboratories (Abbott Park, Illinois) -- Cases -- Intellectual property, Biotechnology -- Cases, Biotechnology industry -- Cases -- Intellectual property, Antirheumatic agents -- Cases, Patent infringement -- Cases, Pharmaceutical industry -- Cases -- Intellectual property, Company legal issue, Business, Business, international
Abstract

M2 PRESSWIRE-February 24, 2011-: Court of Appeals Overturns $1.8 Billion Patent Verdict for Centocor Ortho Biotech Inc.(C)1994-2011 M2 COMMUNICATIONS RDATE:23022011 Horsham, PA -- Centocor Ortho Biotech Inc. (Centocor) today received [...]

Published
2011

2. Neptune Technologies agrees to stay of litigation in patent lawsuit

Subjects
Neptune Technologies & Bioressources Inc. -- Cases -- Intellectual property, Biotechnology industry -- Cases -- Intellectual property, Patent infringement -- Cases, Company legal issue, Chemistry
Abstract

M2 PHARMA-February 3, 2012-Neptune Technologies agrees to stay of litigation in patent lawsuit(C)2012 M2 COMMUNICATIONS 3 February 2012 - Canada's Neptune Technologies and Bioressources Inc (TSE:NTB) has agreed to a [...]

Published
2012

3. Alnylam sues Tekmira for patent breaches

Subjects
Alnylam Pharmaceuticals Inc. -- Cases -- Intellectual property, Biotechnology industry -- Cases -- Intellectual property, Patent infringement -- Cases, Pharmaceutical industry -- Cases -- Intellectual property, Company legal issue, Chemistry
Abstract

M2 PHARMA-January 18, 2012-Alnylam sues Tekmira for patent breaches(C)2012 M2 COMMUNICATIONS 18 January 2012 - US RNAi therapeutics firm Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) said on Tuesday it had lodged a [...]

Published
2012

4. Isis files patent infringement lawsuit against Santaris Pharma

Subjects
Santaris Pharma A/S -- Cases -- Intellectual property, Ionis Pharmaceuticals, Inc. -- Cases -- Intellectual property, Biotechnology industry -- Cases -- Intellectual property, Patent infringement -- Cases, Pharmaceutical industry -- Cases -- Intellectual property, Company legal issue, Business
Abstract

M2 EQUITYBITES-September 26, 2011-Isis files patent infringement lawsuit against Santaris Pharma(C)2011 M2 COMMUNICATIONS http://www.m2.com Antisense technology company Isis Pharmaceuticals Inc (Nasdaq:ISIS) announced on Friday that it has filed a patent [...]

Published
2011

5. Momenta sues Amphastar, Watson, International Medical Systems over patent infringement

Subjects
Momenta Pharmaceuticals Inc. -- Cases -- Intellectual property, Watson Pharmaceuticals Inc. -- Cases -- Intellectual property, International Medical Systems Ltd. -- Cases -- Intellectual property, Medical equipment -- Cases, Biotechnology industry -- Cases -- Intellectual property, Physiological apparatus -- Cases, Patent infringement -- Cases, Pharmaceutical industry -- Cases -- Intellectual property, Company legal issue, Chemistry
Abstract

M2 PHARMA-September 22, 2011-Momenta sues Amphastar, Watson, International Medical Systems over patent infringement(C)2011 M2 COMMUNICATIONS 22 September 2011 - US biotechnology company Momenta Pharmaceuticals Inc (NASDAQ:MNTA) said yesterday that it [...]

Published
2011

6. Court dismisses patent lawsuits against Affymetrix

Subjects
Affymetrix Inc. -- Cases -- Intellectual property, Illumina Inc. -- Cases -- Intellectual property, Biotechnology industry -- Cases -- Intellectual property, Patent infringement -- Cases, Company legal issue, Chemistry
Abstract

M2 PHARMA-August 19, 2011-Court dismisses patent lawsuits against Affymetrix(C)2011 M2 COMMUNICATIONS 19 August 2011 - US laboratory technology company Affymetrix Inc (NASDAQ:AFFX) said today that the US Court of Appeals [...]

Published
2011

7. Genentech, Biogen Idec sue GSK for patent infringement

Subjects
Genentech Inc. -- Cases -- Intellectual property, Biological products industry -- Cases -- Intellectual property, Biotechnology industry -- Cases -- Intellectual property, Patent infringement -- Cases, Pharmaceutical industry -- Cases -- Intellectual property, Company legal issue, Chemistry
Abstract

M2 EUROPHARMA-(C)1999-2010 M2 COMMUNICATIONS 25 March 2010 - US biotechnology companies Genentech (NYSE: DNA) and Biogen Idec (NASDAQ: BIIB) have filed a patent infringement lawsuit against UK drug maker GlaxoSmithKline [...]

Published
2010

8. Cellectricon files patent infringement suit against Fluxion

Subjects
Biotechnology industry -- Cases -- Intellectual property, Patent infringement -- Cases, Company legal issue, Chemistry
Abstract

M2 EUROPHARMA-(C)1999-2010 M2 COMMUNICATIONS 8 February 2010 - Swedish biotech company Cellectricon AB said last Monday it has resumed its litigation against US-based Fluxion Biosciences Inc. Cellectricon filed the lawsuit [...]

Published
2010

Catalog

Books, media, physical & digital resources
See catalog results